Manage external engagement activities including memberships and relationships with professional societies. Manage review process for sponsorship requests. Develop KOL engagement, congress strategies, and insight collection and usage.

Co-founded a Medical Affairs consulting company with over 25 combined years of experience. Specialty in governance process development, process improvement, compliance, investigator initiated research, and more.

Train artificial intelligence to respond better to Science, Technology, Engineering and Mathematics (STEM) prompts. Perform prompt engineering to challenge the capabilities of artificial intelligence in various and diverse competencies. In addition, review, rate, revise or completely re-write artificial intelligence generated responses with a focus on extremely high quality, all to carry out the training goals.

Actively steer, develop, optimize and streamline the global Investigator and Company Sponsored interventional, non-interventional and non-clinical study process, working cross-functionally to understand the needs of different roles and implementing an optimized process. This included setup and oversight of review committees and review and update of optimized SOP and Policy. Major role in building and implementing a state-of-the-art portal platform to digitize the entire clinical and non-clinical study lifecycle including the review and meeting process, enabling accountability, continuous improvements, and good decision-making with transparency and compliance at the forefront. This platform reduced live review committee meetings – with the ability to have comment exchange and decisions given virtually via the platform. It also reduced errors, compliance risks, and non-value adding work and added to the efficient generation of key metrics. Due to its success, the tool was expanded to other company programs, such as Medical Education Grants.Spearheaded training, change management and continuous improvement initiatives which included developing an innovative behavioral-based ISS compliance training taken by 1000+ colleagues. This training received an international e-learning association award with a lasting positive impact on colleagues. Responsibilities included creation of both internal and external process and platform training as well as continuously working with the vendor on enhancements. Acted as Business Administrator for the platform and contributed to URS and UAT.Set up, develop and lead / have oversight of global review process and training for ad hoc approved medication for unapproved use (managed access) requests. Created forms and checklists to ensure adherence to guidelines and compliance. Contributed to creation and maintenance of Policy and provided data and metrics for ethics advisory board presentations and Access To Medicine index reports.

Established and led cross-functional review committees, including with Alliance partners, throughout the lifecycle of Investigator Sponsored and Company Sponsored Studies including strategic fit, study concept, protocol, change requests, amendments, and study reports. Create and present metrics and perform strategic study level assessments of risks to compliance, patients, and programs. Further demonstrate strong leadership by actively steering, managing, and streamlining the governance process; foster cross-functional consensus, and ensure rigorous quality and compliance throughout.Managed all aspects of committee meetings, from collecting submission documents and ensuring their compliance and completeness, preparing and communicating agendas, facilitating meetings and completing and communicating minutes. Handled all aspects of reviews by committees, ensuring comments are collected, compliant, and addressed and proactively addressed queries to prevent issues and maintain timelines for successful review committee oversight of hundreds of studies, helping inform strategy, benefit patients, and advance research.Worked with 60+ countries in a matrixed, multi-cultural environment, regularly using overseas living experience and Portuguese language skills.

Worked closely with multiple drug discovery project teams to manage cell-based assay development, validation and screening for small and large molecule therapeutic targets being developed for projects in immunology and immuno-oncology. Result: Created a new assay using natural killer cells and live cell imaging, as well as streamlined established assays utilizing whole blood and peripheral blood mononuclear cells to make them more high throughput.Led effort to find, evaluate and establish partnerships with CROs, including conducting site visits, working with procurement, and organizing externalized assays for the group. Result: multiple routine assays were externalized, allowing the dedication of more time and effort to optimize existing assays for higher throughput while concurrently developing novel assays for rigorous validation and ultimately screening purposes.Participated in Discovery Technologies departmental strategy planning (must wins scoping), presented to leadership team, and managed action items.

Research focused on determining the regulation of TLR/IL-1R-induced downstream signaling by the protein kinase IRAK4. Worked on a large interdisciplinary project team that together pushed a small molecule therapeutic to first in human safety trials. Results are documented in publications below.Helped evaluate potential new therapeutic targets as part of the exploratory biology group. This included collecting knowledge from the literature, initiating, and participating in international collaborations, networking at conferences, and sharing with the group in the form of presentations and small group discussions. As a result, multiple potential targets were identified and brought for discussion and further evaluation.

Pulmonary DepartmentExpanded my Ph.D. research in the Pulmonary Department to establish new collaborations in academia and publish in vivo effects of loss of miR-29 in transgenic knockout mice (See Publications). In addition, trained medical fellows (pulmonologists) and Ph.D. students in the laboratory.

Department of Medicine, Molecular MedicineThesis: The Role of miR-29 in Pulmonary FibrosisCompleted all courses and research requirements including publishing in a peer-reviewed journal (See publications below). Completed whole genome and miRNA array profiling and data analysis. Presented my research regularly to project teams, in small group meetings, and at internal and external conferences.